Page 32 - Read Online

Xiao et al. Microbiome Res Rep 2024;3:7 https://dx.doi.org/10.20517/mrr.2023.48 Page 9 of 10

31. Bradley BT, Maioli H, Johnston R, et al. Histopathology and ultrastructural findings of fatal COVID-19 infections in Washington
State: a case series. Lancet 2020;396:320-32. DOI PubMed
32. Jiao L, Li H, Xu J, et al. The gastrointestinal tract is an alternative route for SARS-CoV-2 infection in a nonhuman primate model.
Gastroenterology 2021;160:1647-61. DOI PubMed
33. Lamers MM, Beumer J, van der Vaart J, et al. SARS-CoV-2 productively infects human gut enterocytes. Science 2020;369:50-4. DOI
PubMed
34. Katz-Agranov N, Zandman-Goddard G. Autoimmunity and COVID-19 - The microbiotal connection. Autoimmun Rev
2021;20:102865. DOI PubMed
35. de Oliveira AP, Lopes ALF, Pacheco G, de Sá Guimarães Nolêto IR, Nicolau LAD, Medeiros JVR. Premises among SARS-CoV-
2, dysbiosis and diarrhea: walking through the ACE2/mTOR/autophagy route. Med Hypotheses 2020;144:110243. DOI PubMed
36. Patel P, Roper J. Gut microbiome composition is associated with COVID-19 disease severity. Gastroenterology 2021;161:722-4. DOI
PubMed
37. Rawson TM, Moore LSP, Zhu N, et al. Bacterial and fungal coinfection in individuals with coronavirus: a rapid review to support
COVID-19 antimicrobial prescribing. Clin Infect Dis 2020;71:2459-68. DOI PubMed
38. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in
Wuhan, China: a descriptive study. Lancet 2020;395:507-13. DOI PubMed
39. Cox MJ, Loman N, Bogaert D, O’Grady J. Co-infections: potentially lethal and unexplored in COVID-19. Lancet Microbe 2020;1:e11.
DOI PubMed
40. Martins-Filho PR, Tavares CSS, Santos VS. Factors associated with mortality in patients with COVID-19. A quantitative evidence
synthesis of clinical and laboratory data. Eur J Intern Med 2020;76:97-9. DOI PubMed
41. Li J, Richards EM, Handberg EM, Pepine CJ, Raizada MK. Butyrate regulates COVID-19-relevant genes in gut epithelial organoids
from normotensive rats. Hypertension 2021;77:e13-6. DOI PubMed
42. Liu XF, Shao JH, Liao YT, et al. Regulation of short-chain fatty acids in the immune system. Front Immunol 2023;14:1186892. DOI
PubMed
43. Fan L, Xia Y, Wang Y, et al. Gut microbiota bridges dietary nutrients and host immunity. Sci China Life Sci 2023;66:2466-514. DOI
PubMed
44. Zuo T, Liu Q, Zhang F, et al. Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients
with COVID-19. Gut 2021;70:276-84. DOI PubMed
45. Stefan KL, Kim MV, Iwasaki A, Kasper DL. Commensal microbiota modulation of natural resistance to virus infection. Cell
2020;183:1312-24.e10. DOI PubMed
46. Tang L, Gu S, Gong Y, et al. Clinical significance of the correlation between changes in the major intestinal bacteria species and
COVID-19 severity. Engineering 2020;6:1178-84. DOI PubMed
47. Ma N, He T, Johnston LJ, Ma X. Host-microbiome interactions: the aryl hydrocarbon receptor as a critical node in tryptophan
metabolites to brain signaling. Gut Microbes 2020;11:1203-19. DOI PubMed
48. Tsay JCJ, Wu BG, Sulaiman I, et al. Lower airway dysbiosis affects lung cancer progression. Cancer Discov 2021;11:293-307. DOI
PubMed
49. Dhar D, Mohanty A. Gut microbiota and Covid-19- possible link and implications. Virus Res 2020;285:198018. DOI PubMed
50. Mendes de Almeida V, Engel DF, Ricci MF, et al. Gut microbiota from patients with COVID-19 cause alterations in mice that
resemble post-COVID symptoms. Gut Microbes 2023;15:2249146. DOI PubMed
51. Lau HCH, Ng SC, Yu J. Targeting the gut microbiota in coronavirus disease 2019: hype or hope? Gastroenterology 2022;162:9-16.
DOI PubMed
52. Troisi J, Venutolo G, Pujolassos Tanyà M, Delli Carri M, Landolfi A, Fasano A. COVID-19 and the gastrointestinal tract: source of
infection or merely a target of the inflammatory process following SARS-CoV-2 infection? World J Gastroenterol 2021;27:1406-18.
DOI PubMed
53. Wu D, Zhang Y, Dong S, Zhong C. Mutual interaction of microbiota and host immunity during health and diseases. Biophys Rep
2021;7:326-40. DOI PubMed
54. Mozaffari SA, Salehi A, Mousavi E, et al. SARS-CoV-2-associated gut microbiome alteration; A new contributor to colorectal cancer
pathogenesis. Pathol Res Pract 2022;239:154131. DOI PubMed
55. McNabney SM, Henagan TM. Short chain fatty acids in the colon and peripheral tissues: a focus on butyrate, colon cancer, obesity and
insulin resistance. Nutrients 2017;9:1348. DOI PubMed
56. Lo BC, Shin SB, Canals Hernaez D, et al. IL-22 preserves gut epithelial integrity and promotes disease remission during chronic
salmonella infection. J Immunol 2019;202:956-65. DOI PubMed
57. Maruyama D, Liao WI, Tian X, et al. Regulation of lung immune tone by the gut-lung axis via dietary fiber, gut microbiota, and short-
chain fatty acids. bioRxiv 2023;In press. DOI PubMed
58. Cryan JF, O’Riordan KJ, Sandhu K, Peterson V, Dinan TG. The gut microbiome in neurological disorders. Lancet Neurol
2020;19:179-94. DOI PubMed
59. Hashimoto K. Detrimental effects of COVID-19 in the brain and therapeutic options for long COVID: the role of Epstein-Barr virus
and the gut-brain axis. Mol Psychiatry 2023;In press. DOI PubMed
60. Luo J, Liang S, Jin F. Gut microbiota in antiviral strategy from bats to humans: a missing link in COVID-19. Sci China Life Sci